Afrezza® INHALE-1 Study in Pediatrics

Clinical trial NCT04974528 · COMPLETED

Trial details

NCT number: NCT04974528
Sponsor: Mannkind Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 1 Diabetes Mellitus, Type 2

Start date: 2021-09-29
Primary completion: 2024-10-03
Enrollment: 319

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.